See you next year! October 2025
JapanDelivered as a Hybrid Event
Dr. Hiroko Yamashita, PhDSenior Scientist, Mid-Size Molecule Unit at Chugai Pharmabody ResearchSpeaker
Profile
Hiroko Yamashita received her B.E. and M.E. degrees in biomolecular engineering from Tokyo Institute of Technology, Japan, in 2014 and 2016, respectively, and her Ph.D. in pharmaceutical sciences from the University of Tokyo, Japan, in 2019. After that, she joined Chugai Pharmaceutical Co., Ltd. and moved to Chugai Pharmabody Research Pte. Ltd. as a senior scientist in 2022. Her work focuses specifically on the new technology development for discovering peptide-based drugs.
Agenda Sessions
New Methodology for Discovering An Orally Bioavailable Peptide and Its Application for Developing a RAS Inhibitor
, 17:30View Session